January 10, 2026 article Open access DNA-based vaccines: Advances, applications, and future prospects Genes & Diseases DOI: 10.1016/j.gendis.2025.102025 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 3 References 10 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses 2020 npj Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 21 patents 357 citations Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S 2022 New England Journal of Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access 243 citations Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial 2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents 173 citations Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming 2022 New England Journal of Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access 124 citations Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial 2021 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access 96 citations Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial 2022 The Lancet Infectious Diseases article Medicine SARS-CoV-2 and COVID-19 Research Open access 84 citations A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine 2021 Annals of Internal Medicine article Medicine Mosquito-borne diseases and control 80 citations Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study 2022 The Journal of Infectious Diseases article Immunology and Microbiology HIV Research and Treatment Open access 39 citations Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice 2023 npj Vaccines article Medicine Tuberculosis Research and Epidemiology Open access cited by 1 patent 26 citations Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 7 citations 10 results